FDA has pressing questions about safety and efficacy of CBD when used by specific populations and for specific purposes.
ValidCare is opening its consumer experience platform for 60 days to collect the detailed, Real World Evidence (RWE) that answers FDA’s most pressing questions.
Welcome to the National Consumer Experience Program from ValidCare. You can offer this program to your consumers, who can actively participate in this program by downloading a free app and tracking their CBD experiences. Your CBD product manufacturing organization will have access to RWE related to its products and consumers from September 1 through October 31, 2019. RWE submitted by consumers will be shared with FDA while protecting company specific IP and consumer identities.
Join us in validating CBD’s effects and ensuring FDA has the data it needs to properly regulate hemp derived CBD.
To sign up or inquire about program specifics, click below based on your association affiliations: